newdrugapprovals.org
FDA approves first treatment Givlaari (givosiran) for inherited rare disease
Today, the U.S. Food and Drug Administration granted approval to Givlaari (givosiran) for the treatment of adult patients with acute hepatic porphyria, a genetic disorder resulting in the buildup o…